Ann: Advanced Notice Shareholder Briefing, page-63

what to expect from David's webinar on Wednesday.

before I start I want a deal, every shareholder wants a deal, (so nobody needs to post I want a deal reply ) but as an investor I want to have a wider and longer term vision of the company presented.

- whats happening with our Eugeni covid test, common list trial was terminated but we still have CE mark and last I heard MHRA trial

- progress on covid/flu multiplex test and sepsis test

-Life science initiatives and short term revenue streams. what is the strategy involving partnerships, jv's and acquisitions

-anteoX commercial pipeline. how are Enax, global battery manufacture who validated Anteox's performance and other partners progressing?

-how is the gen 2 high silicon trial progressing. should be well over 500 cycles and closing in on 1000 cycles

-pilot plant progress

- future energy projects, hydrogen and cathodes

-website

-what is the deal with the advisory company appointed "to actively pursue potential grant opportunities to support the CET division through the addition of non-dilutive funding opportunities for ongoing product development."

I'm sure there is more, all the above were mention in the last 4c. IMO plenty happening at ADO headquarters. be David's 1st test in how much and how well he presents it to the shareholders. I'm hoping for a progress report and a vision of clear and concise deliverables and timeframes of the remaining 2023. cmon Dave and ADO.....

ps. again I want a deal to be announced.